🔧На сайте запланированы технические работы
25.12.2025 в промежутке с 18:00 до 21:00 по Московскому времени (GMT+3) на сайте будут проводиться плановые технические работы. Возможны перебои с доступом к сайту. Приносим извинения за временные неудобства. Благодарим за понимание!
🔧Site maintenance is scheduled.
Scheduled maintenance will be performed on the site from 6:00 PM to 9:00 PM Moscow time (GMT+3) on December 25, 2025. Site access may be interrupted. We apologize for the inconvenience. Thank you for your understanding!

 

Design of New Uracil Derivatives Possessing Inhibitory Activity with Respect to Reverse Transcriptase of HIV-1 Mutant K103N/Y181C


如何引用文章

全文:

开放存取 开放存取
受限制的访问 ##reader.subscriptionAccessGranted##
受限制的访问 订阅存取

详细

New highly active N1-substituted uracil derivatives of the HIV-1 nonnucleoside reverse transcriptase inhibitor class were designed. The structure—activity relationship provided a basis for building a computer model of the inhibitory activity against reverse transcriptase of HIV-1 mutant K103N/Y181C. New compounds that were more active than nevirapine were synthesized.

作者简介

S. Pechinskii

Pyatigorsk Medico-Pharmaceutical Institute, Branch of Volgograd State Medical University

Email: chem@folium.ru
俄罗斯联邦, MH RF, Pyatigorsk, 357532

A. Kuregyan

Pyatigorsk Medico-Pharmaceutical Institute, Branch of Volgograd State Medical University

Email: chem@folium.ru
俄罗斯联邦, MH RF, Pyatigorsk, 357532

A. Ozerov

Volgograd State Medical University, MH RF

Email: chem@folium.ru
俄罗斯联邦, Volgograd, 400131

M. Novikov

Volgograd State Medical University, MH RF

Email: chem@folium.ru
俄罗斯联邦, Volgograd, 400131

补充文件

附件文件
动作
1. JATS XML

版权所有 © Springer Science+Business Media New York, 2016